eCARTv5 Clinical Deterioration Suite (eCART) vs WellSky SkySense AI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

eCARTv5 Clinical Deterioration Suite (eCART)

by AgileMD

WellSky SkySense AI

by WellSky

AI Verdict

Tool A, AgileMD's eCARTv5, is an FDA-cleared clinical decision support system focused on predicting and managing patient deterioration in hospitalized adults. Tool B, WellSky SkySense AI, offers a suite of AI tools primarily aimed at reducing documentation burden and improving efficiency within WellSky's EHRs, particularly for home health and post-acute care. While both leverage AI and integrate with EHRs, their core functionalities and target clinical problems are distinct, making them adjacent rather than direct competitors.

Choose eCARTv5 Clinical Deterioration Suite (eCART) if…

Choose eCARTv5 Clinical Deterioration Suite if your primary goal is to proactively identify and manage hospitalized adult patients at risk of clinical deterioration (death or ICU transfer). This FDA-cleared, AI-powered SaMD continuously assesses patient risk using real-time EHR data and guides care with embedded clinical pathways, aiming to reduce adverse outcomes and clinician workload.

View eCARTv5 Clinical Deterioration Suite (eCART) →

Choose WellSky SkySense AI if…

Choose WellSky SkySense AI if your organization seeks to significantly reduce documentation burden and improve administrative efficiency within home health, hospice, palliative, or post-acute care settings. Its AI-powered tools, including ambient listening and transcription, medication reconciliation, and automated clinical summaries, are designed to free up clinician time for direct patient engagement and enhance data accuracy.

View WellSky SkySense AI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	eCARTv5 Clinical Deterioration Suite (eCART)	WellSky SkySense AI
Pricing	Contact vendor for tailored quote.	Unknown
Deployment	Cloud-based SaaS, integrated directly into Electronic Health Record (EHR) systems.	Cloud-based, with mobile apps for Android and iOS.
FDA Status	1 AI-estimated	No AI-estimated
EHR Integration	Not specified	wellsky

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

AgileMD's eCARTv5 is praised for its seamless EHR integration, intuitive user interface, and interactive decision trees that guide clinicians. WellSky SkySense AI, particularly WellSky Scribe, is also noted for reducing documentation time by up to 50% and improving clinician satisfaction through its integrated and mobile-optimized workflows. Both tools aim to streamline clinical processes and reduce clinician burden, suggesting a comparable focus on usability.

Clinical Value

eCARTv5 Clinical Deterioration Suite (eCART)

AgileMD's eCARTv5 is an FDA-cleared Software as a Medical Device (SaMD) that continuously assesses and predicts the risk of clinical deterioration (death or ICU transfer) in hospitalized adult patients, with strong clinical validation across diverse patient populations. WellSky SkySense AI focuses on improving documentation efficiency, medication reconciliation, and clinical summaries, which indirectly support clinical value but do not offer direct patient risk prediction or FDA clearance as a medical device.

Pricing & Value

Tie

Both AgileMD eCARTv5 and WellSky SkySense AI do not publicly list their pricing, instead requiring prospective customers to contact the vendor for a tailored quote. WellSky does offer a free trial for WellSky SkySense AI to users of WellSky Home Health for a limited period. Without transparent pricing, it is difficult to definitively compare their value propositions.

Enterprise Readiness

WellSky SkySense AI

WellSky SkySense AI is embedded within WellSky's EHRs and serves over 20,000 client sites, including large hospital systems and post-acute providers, demonstrating extensive enterprise adoption and integration capabilities. AgileMD's eCARTv5 also integrates with EHRs and has been deployed in over 400 hospitals with 150,000+ clinical users, but WellSky's broader client base and integration within its own EHR platform suggest a wider enterprise footprint.

Innovation

eCARTv5 Clinical Deterioration Suite (eCART)

AgileMD's eCARTv5 leverages a gradient-boosted machine learning model trained on a large dataset to predict clinical deterioration, a complex and critical task in acute care. WellSky SkySense AI offers innovative features like ambient listening and transcription, and AI-powered extraction for documentation, but these primarily focus on automating existing administrative tasks rather than novel predictive analytics for patient outcomes.

Support & Docs

Tie

Neither the provided structured facts nor the web search results offer specific details about the depth or accessibility of support and documentation for either AgileMD eCARTv5 or WellSky SkySense AI. While both companies are established in the healthcare AI space, there is insufficient information to distinguish them on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	eCARTv5 Clinical Deterioration Suite (eCART)	WellSky SkySense AI
Name	eCARTv5 Clinical Deterioration Suite (u201ceCARTu201d)	WellSky SkySense AI
Company	AgileMD	WellSky
Description	FDA-cleared, AI-powered Software as a Medical Device (SaMD) that integrates with EHRs to continuously assess and predict the risk of clinical deterioration (death or ICU transfer) in hospitalized adult patients, guiding care with embedded clinical pathways.	A suite of AI-powered tools embedded in their EHRs, including ambient listening and transcription, AI-powered extraction for medication reconciliation and referrals, and clinical summaries.
Key Features	AI-powered clinical deterioration prediction, Continuous patient risk assessment (death or ICU transfer), EHR integration with real-time data (up to 97 variables), Embedded clinical pathways for care guidance, Early warning system (alerts hours before critical illness), Risk stratification (eCART score and risk designation), Minimizes false alarms and clinician workload, Reporting and benchmarking capabilities	Ambient listening and transcription (WellSky Scribe), AI-powered medication reconciliation, AI-powered referral information extraction, Automated clinical summary generation, Integration with WellSky EHRs, Reduced documentation burden, Enhanced data accuracy
Specialties	Critical Care, Emergency Medicine, Hospital Medicine	home-health, hospice, Palliative Care, post-acute-care
Free Trial	Not specified	yes, a free trial of wellsky skysense ai is offered to users of wellsky home health from november 4, 2025, to january 15, 2026.

Videos

Demos, reviews, and walkthroughs featuring eCARTv5 Clinical Deterioration Suite (eCART) and WellSky SkySense AI.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools fit into a physician's existing workflow, and what is the learning curve like for each?

eCARTv5 is designed to integrate with EHRs to provide continuous patient risk assessment and guide care with embedded clinical pathways, suggesting a workflow that incorporates real-time alerts and standardized guidance for high-risk patients. WellSky SkySense AI, conversely, focuses on streamlining documentation through ambient listening and transcription, medication reconciliation, and clinical summary generation, aiming to reduce administrative burden and allow more direct patient engagement. The learning curve for WellSky SkySense AI appears to be mitigated by its direct integration into existing WellSky EHR workflows and its focus on automating routine documentation tasks.

What is the depth of EHR integration for each tool, and how does it impact data utilization?

eCARTv5 integrates directly into EHR systems, continuously analyzing up to 97 real-time variables, including laboratory results, vital signs, and nursing assessments, to generate an eCART score and risk designation. This deep integration allows for comprehensive data utilization to predict clinical deterioration. WellSky SkySense AI is embedded within WellSky's own EHR platforms, offering AI-powered tools like WellSky Extract for populating data from documents and images, WellSky Scribe for transcribing patient visits into clinical documentation, and WellSky Summarize for generating clinical summaries. This integration aims to automate data entry and enhance data accuracy within the WellSky ecosystem.

What are the accuracy and sensitivity of each tool in their respective clinical applications?

eCARTv5 has demonstrated high accuracy in identifying early clinical deterioration, with an AUROC of 0.834 in retrospective validation, outperforming other early warning scores. Its performance remained high across diverse patient demographics and clinical conditions during prospective validation. For WellSky SkySense AI, while specific accuracy and sensitivity metrics for its AI components are not provided, it aims to improve documentation quality and consistency, and reduce documentation errors through its AI-powered extraction, transcription, and summarization tools.

Which clinical specialties are best suited for each tool, and how do they address specific needs within those specialties?

eCARTv5 is specifically designed for critical care, emergency medicine, and hospital medicine, focusing on hospitalized adult patients to predict clinical deterioration (death or ICU transfer) and guide care with embedded clinical pathways. WellSky SkySense AI is tailored for home health, hospice, palliative care, and post-acute care settings, aiming to reduce documentation burden, improve medication reconciliation, expedite referral processing, and generate clinical summaries, thereby enhancing efficiency and patient engagement in these specific care environments.

What kind of support and resources are available to help physicians optimize their use of these tools?

While specific details on support quality for eCARTv5 are not provided, its integration with clinical pathways suggests a structured approach to guidance. WellSky SkySense AI, being embedded within WellSky's platform, likely benefits from WellSky's established support infrastructure for its EHR users. WellSky also offers resources like a resource hub with thought leadership content and practical guidance for AI adoption, and a conversational voice assistant (WellSky Intelligent Language Assistant) to help clinicians with documentation questions.

What are the considerations for rolling out these tools across multiple sites or a large healthcare system?

eCARTv5 has been validated in a multicenter setting across 21 hospitals, indicating its suitability for multi-site deployment and consistent accuracy across diverse patient demographics and medical conditions. WellSky SkySense AI is integrated into WellSky's EHRs, which serve over 20,000 client sites, including large hospital systems and post-acute providers, suggesting a scalable solution for multi-site rollouts within the WellSky ecosystem.